 | • レポートコード：QYR9NV07249 • 出版社/出版日：QYResearch / 2019年11月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、LAMEA腫瘍/抗癌剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、血液癌、乳癌、胃腸癌、前立腺癌、その他に、用途別には、化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、その他にセグメント区分し、LAMEA腫瘍/抗癌剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・LAMEA腫瘍/抗癌剤の世界市場概要 ・LAMEA腫瘍/抗癌剤の製造コスト構成分析 ・LAMEA腫瘍/抗癌剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・LAMEA腫瘍/抗癌剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・LAMEA腫瘍/抗癌剤のセグメント分析（種類別） （血液癌、乳癌、胃腸癌、前立腺癌、その他） ・LAMEA腫瘍/抗癌剤のセグメント分析（用途別） （化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、その他） ・LAMEA腫瘍/抗癌剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Roche、Novartis、Celgene、Amgen、Johnson & Johnson、GlaxoSmithKline、Eli lilly & Co、Pfizer、Merck & Co.、Sanofi、） ・LAMEA腫瘍/抗癌剤の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global LAMEA Oncology/Anti-cancer drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on LAMEA Oncology/Anti-cancer drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall LAMEA Oncology/Anti-cancer drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of LAMEA Oncology/Anti-cancer drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their LAMEA Oncology/Anti-cancer drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Others
Segment by Application
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Table of Contents
Executive Summary
1 Industry Overview of LAMEA Oncology/Anti-cancer drugs
1.1 Definition of LAMEA Oncology/Anti-cancer drugs
1.2 LAMEA Oncology/Anti-cancer drugs Segment by Type
1.2.1 Global LAMEA Oncology/Anti-cancer drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Blood Cancer
1.2.3 Breast Cancer
1.2.4 Gastrointestinal Cancer
1.2.5 Prostate Cancer
1.2.6 Others
1.3 LAMEA Oncology/Anti-cancer drugs Segment by Applications
1.3.1 Global LAMEA Oncology/Anti-cancer drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy (Biologic Therapy)
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Global LAMEA Oncology/Anti-cancer drugs Overall Market
1.4.1 Global LAMEA Oncology/Anti-cancer drugs Revenue (2014-2025)
1.4.2 Global LAMEA Oncology/Anti-cancer drugs Production (2014-2025)
1.4.3 North America LAMEA Oncology/Anti-cancer drugs Status and Prospect (2014-2025)
1.4.4 Europe LAMEA Oncology/Anti-cancer drugs Status and Prospect (2014-2025)
1.4.5 China LAMEA Oncology/Anti-cancer drugs Status and Prospect (2014-2025)
1.4.6 Japan LAMEA Oncology/Anti-cancer drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia LAMEA Oncology/Anti-cancer drugs Status and Prospect (2014-2025)
1.4.8 India LAMEA Oncology/Anti-cancer drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of LAMEA Oncology/Anti-cancer drugs
2.3 Manufacturing Process Analysis of LAMEA Oncology/Anti-cancer drugs
2.4 Industry Chain Structure of LAMEA Oncology/Anti-cancer drugs
3 Development and Manufacturing Plants Analysis of LAMEA Oncology/Anti-cancer drugs
3.1 Capacity and Commercial Production Date
3.2 Global LAMEA Oncology/Anti-cancer drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of LAMEA Oncology/Anti-cancer drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 LAMEA Oncology/Anti-cancer drugs Production and Capacity Analysis
4.2 LAMEA Oncology/Anti-cancer drugs Revenue Analysis
4.3 LAMEA Oncology/Anti-cancer drugs Price Analysis
4.4 Market Concentration Degree
5 LAMEA Oncology/Anti-cancer drugs Regional Market Analysis
5.1 LAMEA Oncology/Anti-cancer drugs Production by Regions
5.1.1 Global LAMEA Oncology/Anti-cancer drugs Production by Regions
5.1.2 Global LAMEA Oncology/Anti-cancer drugs Revenue by Regions
5.2 LAMEA Oncology/Anti-cancer drugs Consumption by Regions
5.3 North America LAMEA Oncology/Anti-cancer drugs Market Analysis
5.3.1 North America LAMEA Oncology/Anti-cancer drugs Production
5.3.2 North America LAMEA Oncology/Anti-cancer drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America LAMEA Oncology/Anti-cancer drugs Import and Export
5.4 Europe LAMEA Oncology/Anti-cancer drugs Market Analysis
5.4.1 Europe LAMEA Oncology/Anti-cancer drugs Production
5.4.2 Europe LAMEA Oncology/Anti-cancer drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe LAMEA Oncology/Anti-cancer drugs Import and Export
5.5 China LAMEA Oncology/Anti-cancer drugs Market Analysis
5.5.1 China LAMEA Oncology/Anti-cancer drugs Production
5.5.2 China LAMEA Oncology/Anti-cancer drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China LAMEA Oncology/Anti-cancer drugs Import and Export
5.6 Japan LAMEA Oncology/Anti-cancer drugs Market Analysis
5.6.1 Japan LAMEA Oncology/Anti-cancer drugs Production
5.6.2 Japan LAMEA Oncology/Anti-cancer drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan LAMEA Oncology/Anti-cancer drugs Import and Export
5.7 Southeast Asia LAMEA Oncology/Anti-cancer drugs Market Analysis
5.7.1 Southeast Asia LAMEA Oncology/Anti-cancer drugs Production
5.7.2 Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia LAMEA Oncology/Anti-cancer drugs Import and Export
5.8 India LAMEA Oncology/Anti-cancer drugs Market Analysis
5.8.1 India LAMEA Oncology/Anti-cancer drugs Production
5.8.2 India LAMEA Oncology/Anti-cancer drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India LAMEA Oncology/Anti-cancer drugs Import and Export
6 LAMEA Oncology/Anti-cancer drugs Segment Market Analysis (by Type)
6.1 Global LAMEA Oncology/Anti-cancer drugs Production by Type
6.2 Global LAMEA Oncology/Anti-cancer drugs Revenue by Type
6.3 LAMEA Oncology/Anti-cancer drugs Price by Type
7 LAMEA Oncology/Anti-cancer drugs Segment Market Analysis (by Application)
7.1 Global LAMEA Oncology/Anti-cancer drugs Consumption by Application
7.2 Global LAMEA Oncology/Anti-cancer drugs Consumption Market Share by Application (2014-2019)
8 LAMEA Oncology/Anti-cancer drugs Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celgene
8.3.1 Celgene LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.3.2 Celgene Product Introduction, Application and Specification
8.3.3 Celgene LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Amgen
8.4.1 Amgen LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.4.2 Amgen Product Introduction, Application and Specification
8.4.3 Amgen LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Eli lilly & Co
8.7.1 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.7.2 Eli lilly & Co Product Introduction, Application and Specification
8.7.3 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Pfizer
8.8.1 Pfizer LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.8.2 Pfizer Product Introduction, Application and Specification
8.8.3 Pfizer LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Merck & Co.
8.9.1 Merck & Co. LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.9.2 Merck & Co. Product Introduction, Application and Specification
8.9.3 Merck & Co. LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Sanofi
8.10.1 Sanofi LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
8.10.2 Sanofi Product Introduction, Application and Specification
8.10.3 Sanofi LAMEA Oncology/Anti-cancer drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of LAMEA Oncology/Anti-cancer drugs Market
9.1 Global LAMEA Oncology/Anti-cancer drugs Market Trend Analysis
9.1.1 Global LAMEA Oncology/Anti-cancer drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 LAMEA Oncology/Anti-cancer drugs Regional Market Trend
9.2.1 North America LAMEA Oncology/Anti-cancer drugs Forecast 2019-2025
9.2.2 Europe LAMEA Oncology/Anti-cancer drugs Forecast 2019-2025
9.2.3 China LAMEA Oncology/Anti-cancer drugs Forecast 2019-2025
9.2.4 Japan LAMEA Oncology/Anti-cancer drugs Forecast 2019-2025
9.2.5 Southeast Asia LAMEA Oncology/Anti-cancer drugs Forecast 2019-2025
9.2.6 India LAMEA Oncology/Anti-cancer drugs Forecast 2019-2025
9.3 LAMEA Oncology/Anti-cancer drugs Market Trend (Product Type)
9.4 LAMEA Oncology/Anti-cancer drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 LAMEA Oncology/Anti-cancer drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of LAMEA Oncology/Anti-cancer drugs
Table Global LAMEA Oncology/Anti-cancer drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global LAMEA Oncology/Anti-cancer drugs Production Market Share by Types in 2018
Figure Blood Cancer Product Picture
Figure Breast Cancer Product Picture
Figure Gastrointestinal Cancer Product Picture
Figure Prostate Cancer Product Picture
Figure Others Product Picture
Table Global LAMEA Oncology/Anti-cancer drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global LAMEA Oncology/Anti-cancer drugs Consumption Market Share by Applications in 2018
Figure Chemotherapy
Figure Targeted Therapy
Figure Immunotherapy (Biologic Therapy)
Figure Hormonal Therapy
Figure Others
Figure Global LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) (2014-2025)
Figure Global LAMEA Oncology/Anti-cancer drugs Production (K Units) (2014-2025)
Figure North America LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) (2014-2025)
Figure Europe LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) (2014-2025)
Figure China LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) (2014-2025)
Figure Japan LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) (2014-2025)
Figure India LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) (2014-2025)
Table LAMEA Oncology/Anti-cancer drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of LAMEA Oncology/Anti-cancer drugs in 2018
Figure Manufacturing Process Analysis of LAMEA Oncology/Anti-cancer drugs
Figure Industry Chain Structure of LAMEA Oncology/Anti-cancer drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global LAMEA Oncology/Anti-cancer drugs Manufacturing Plants Distribution
Table LAMEA Oncology/Anti-cancer drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table LAMEA Oncology/Anti-cancer drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table LAMEA Oncology/Anti-cancer drugs Production (K Units) of Major Manufacturers (2014-2019)
Table LAMEA Oncology/Anti-cancer drugs Production Market Share of Major Manufacturers (2014-2019)
Figure LAMEA Oncology/Anti-cancer drugs Production Share by Manufacturers in 2018
Table LAMEA Oncology/Anti-cancer drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table LAMEA Oncology/Anti-cancer drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure LAMEA Oncology/Anti-cancer drugs Revenue Share by Manufacturers in 2018
Table LAMEA Oncology/Anti-cancer drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global LAMEA Oncology/Anti-cancer drugs Production by Regions 2014-2019 (K Units)
Table Global LAMEA Oncology/Anti-cancer drugs Production Market Share by Regions 2014-2019
Figure Global LAMEA Oncology/Anti-cancer drugs Production Market Share by Regions in 2018
Table Global LAMEA Oncology/Anti-cancer drugs Revenue by Regions 2014-2019 (Million USD)
Table Global LAMEA Oncology/Anti-cancer drugs Revenue Market Share by Regions 2014-2019
Figure Global LAMEA Oncology/Anti-cancer drugs Revenue Market Share by Regions in 2018
Table Global LAMEA Oncology/Anti-cancer drugs Consumption by Regions 2014-2019 (K Units)
Table Global LAMEA Oncology/Anti-cancer drugs Consumption Market Share by Regions 2014-2019
Figure North America LAMEA Oncology/Anti-cancer drugs Production Growth Rate 2014-2019 (K Units)
Figure North America LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America LAMEA Oncology/Anti-cancer drugs Production, Consumption Import and Export (K Units)
Figure Europe LAMEA Oncology/Anti-cancer drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe LAMEA Oncology/Anti-cancer drugs Production, Consumption Import and Export (K Units)
Figure China LAMEA Oncology/Anti-cancer drugs Production Growth Rate 2014-2019 (K Units)
Figure China LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China LAMEA Oncology/Anti-cancer drugs Production, Consumption Import and Export (K Units)
Figure Japan LAMEA Oncology/Anti-cancer drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan LAMEA Oncology/Anti-cancer drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia LAMEA Oncology/Anti-cancer drugs Production, Consumption Import and Export (K Units)
Figure India LAMEA Oncology/Anti-cancer drugs Production Growth Rate 2014-2019 (K Units)
Figure India LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India LAMEA Oncology/Anti-cancer drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption LAMEA Oncology/Anti-cancer drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) LAMEA Oncology/Anti-cancer drugs Market Share by Application (2014-2019)
Table Roche LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Roche LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Roche LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Roche LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Roche LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Roche LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Novartis LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Novartis LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Novartis LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Novartis LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Novartis LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Novartis LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Celgene LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Celgene LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Celgene LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celgene LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Celgene LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Celgene LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Celgene LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Amgen LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Amgen LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Amgen LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Amgen LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Amgen LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Amgen LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Pfizer LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Pfizer LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Pfizer LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Pfizer LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Pfizer LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Pfizer LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Merck & Co. LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Table Sanofi LAMEA Oncology/Anti-cancer drugs Production Sites and Area Served
Table Sanofi LAMEA Oncology/Anti-cancer drugs Product Introduction, Application and Specification
Table Sanofi LAMEA Oncology/Anti-cancer drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi LAMEA Oncology/Anti-cancer drugs Production Growth Rate (2014-2019)
Table Sanofi LAMEA Oncology/Anti-cancer drugs Production Market Share (2014-2019)
Figure Sanofi LAMEA Oncology/Anti-cancer drugs Revenue Market Share (2014-2019)
Table Sanofi LAMEA Oncology/Anti-cancer drugs Main Business and Markets Served
Figure Global LAMEA Oncology/Anti-cancer drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America LAMEA Oncology/Anti-cancer drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe LAMEA Oncology/Anti-cancer drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China LAMEA Oncology/Anti-cancer drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan LAMEA Oncology/Anti-cancer drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India LAMEA Oncology/Anti-cancer drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of LAMEA Oncology/Anti-cancer drugs by Type (2019-2025)
Table Global Consumption (K Units) of LAMEA Oncology/Anti-cancer drugs by Application (2019-2025)
Table LAMEA Oncology/Anti-cancer drugs Distributors List
Table LAMEA Oncology/Anti-cancer drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
腫瘍学/がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Medical oncologists specialise in cancer treatment using drugs such as chemotherapy agents. Scope of the Report: This report focuses on the Oncology/Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the…- 食道癌治療薬のグローバル市場：規模・現状・予測2019-2025 Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
- 食道癌治療薬のグローバル市場：規模・現状・予測2019-2025 Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
- がん支持療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. Scope of the Report: This report …
- 植物源抗がん剤のグローバル市場調査 2019年 The global Plant Sources Anti Cancer Agents market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Plant Sources Anti Cancer Agents volume and value at global level, regional level and company level. From …